Table 1 PAK5 and p65 staining and clinicopathologic characteristics of breast cancer patients
PAK5 staining (n = 129) | p65 staining (n = 119) | |||||||
|---|---|---|---|---|---|---|---|---|
Variables | Low (%) | High (%) | Total | P value | Low (%) | High (%) | Total | P value |
Age | ||||||||
< 50 years | 14 (38.9) | 22 (61.1) | 36 | 0.558 | 13 (40.6) | 19 (59.4) | 32 | 0.409 |
≥ 50 years | 42 (45.2) | 51 (54.8) | 93 | 44 (50.6) | 43 (49.4) | 87 | ||
pT status | ||||||||
pT0-pT1 | 23 (69.7) | 10 (30.3) | 33 | 0.000 | 21 (63.6) | 12 (36.4) | 33 | 0.039 |
pT2- pT4 | 29 (30.9) | 65 (69.1) | 94 | 34 (40.5) | 50 (59.5) | 84 | ||
pN status | ||||||||
pN0 | 34 (50.7) | 33 (49.3) | 67 | 0.011 | 36 (59.0) | 25 (41.0) | 61 | 0.018 |
pN1- pN3 | 17 (27.9) | 44 (72.1) | 61 | 21 (36.8) | 36 (63.2) | 57 | ||
TNM stage | ||||||||
I~II | 32 (50.8) | 31 (49.2) | 63 | 0.03 | 36 (59.0) | 25 (41.0) | 61 | 0.018 |
I~III | 11 (32.4) | 23 (67.6) | 34 | 14 (43.8) | 18 (56.2) | 32 | ||
III | 5 (21.7) | 18 (78.3) | 23 | 4 (22.2) | 14 (51.4) | 18 | ||